首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   36795篇
  免费   3834篇
  国内免费   1241篇
耳鼻咽喉   75篇
儿科学   1313篇
妇产科学   200篇
基础医学   3158篇
口腔科学   155篇
临床医学   3340篇
内科学   4888篇
皮肤病学   271篇
神经病学   535篇
特种医学   864篇
外国民族医学   1篇
外科学   14343篇
综合类   5299篇
现状与发展   2篇
一般理论   1篇
预防医学   1139篇
眼科学   201篇
药学   2558篇
  18篇
中国医学   2786篇
肿瘤学   723篇
  2024年   131篇
  2023年   855篇
  2022年   1374篇
  2021年   2313篇
  2020年   1676篇
  2019年   1891篇
  2018年   1739篇
  2017年   1650篇
  2016年   1663篇
  2015年   1719篇
  2014年   2518篇
  2013年   2607篇
  2012年   1867篇
  2011年   2172篇
  2010年   1872篇
  2009年   1655篇
  2008年   1679篇
  2007年   1598篇
  2006年   1501篇
  2005年   1326篇
  2004年   1130篇
  2003年   988篇
  2002年   824篇
  2001年   768篇
  2000年   556篇
  1999年   469篇
  1998年   372篇
  1997年   306篇
  1996年   310篇
  1995年   297篇
  1994年   260篇
  1993年   193篇
  1992年   200篇
  1991年   185篇
  1990年   131篇
  1989年   144篇
  1988年   116篇
  1987年   105篇
  1986年   83篇
  1985年   90篇
  1984年   83篇
  1983年   51篇
  1982年   58篇
  1981年   59篇
  1980年   49篇
  1979年   53篇
  1978年   40篇
  1977年   38篇
  1976年   29篇
  1975年   24篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
BACKGROUND: Routine cytomegalovirus (CMV)-pp65 antigenaemia monitoring shows that some patients will develop pp65 antigenaemia during valaciclovir prophylaxis or after cessation of treatment. The aim of this pilot study was to evaluate the safety and efficacy of lowering immunosuppression in kidney transplant recipients who exhibit mildly symptomatic CMV infections while on valaciclovir prophylaxis. METHODS: We selected 12 patients who experienced mildly symptomatic CMV infections defined as a positive CMV-pp65 antigenaemia test associated with either neutropenia, asthenia or arthralgia, but no fever. All of them received prophylaxis with valaciclovir for at least 3 months. Testing for CMV-pp65 antigenaemia was performed weekly for 6 months. RESULTS: The mildly symptomatic infections occurred at a median interval of 69 days after transplantation-during prophylaxis in eight cases and after valaciclovir discontinuation in the other four cases. All of them were effectively managed by lowering immunosuppressive therapy, leading to the disappearance of symptoms and CMV antigenaemia reduction. No immunological complication or recurrence of CMV infection or disease was noted. I.v. ganciclovir never became necessary. CONCLUSION: The mildly symptomatic CMV infections occurring in valaciclovir-treated patients may be managed efficiently and without immunologic complication by lowering immunosuppressive therapy.  相似文献   
102.
基于中医有关古代文献和个人的临床经验,作者举例说明咳嗽不仅能从肺治疗,从肾治疗也是行之有效的方法。  相似文献   
103.
目的为探讨肾输尿管结石的临床特点,以提出更好的防治措施。方法对原西南师范大学医院1997-2004年治疗的128例肾输尿管结石病例的临床资料进行统计分析。结果本组病例男女之比为2.05∶1,29岁以下发病103例,占80.5%。2001年起发病呈上升趋势,2003年最高。每年9-10月是发病高峰,占本组病例的31.2%。经体外震波碎石99例,3个月结石排净率为83%,与文献报道的基本一致。结论该校肾输尿管结石患者,男性多于女性,30岁以下居多。发病近年增加,体外震波碎石疗效好。  相似文献   
104.
105.
BACKGROUND: Interleukin-6 (IL-6) is a multifunctional cytokine which regulates immune responses and host defence mechanisms. IL-6 has been found to be increased in certain inflammatory conditions of the kidney, in which tubular epithelial cells play a pivotal role. Human renal tubular cells express IL-6. Until now no data about the effect of the immunosuppressant drug mycophenolic acid (MPA) on IL-6 expression were available. METHODS: Proximal and distal tubular epithelial cells (PTC/DTC) have been isolated immunomagnetically. Confluent monolayers were stimulated with interleukin-1beta (IL-1beta; 25 U/ml), IL-1beta+ MPA (0.25-50 micro M) or MPA alone for 48 h. Release of IL-6 protein into the supernatant was evaluated with an enzyme immunoassay, IL-6 mRNA expression was evaluated using the Quantikine mRNA kit. RESULTS: After IL-1beta stimulation, a highly significant 2.6- (PTC) and 3.8-fold (DTC) upregulation of IL-6 expression was detectable. IL-6 mRNA was upregulated by IL-1beta [1.57- (PTC) and 2.03-fold (DTC)]. MPA inhibited this cytokine-induced IL-6 expression in a dose-dependent manner. Incubation with the lowest MPA concentration had no effect on the stimulated upregulation, whereas all higher doses significantly decreased IL-6 expression. Dexamethasone significantly inhibited the cytokine-induced IL-6 protein release in PTC, but not in DTC. CONCLUSIONS: In this study we demonstrated for the first time an inhibitory effect of MPA on the stimulated IL-6 expression of renal tubular epithelial cells. In contrast to older data, which showed a synergistic upregulation of the expression of a CC-chemokine by a combination of cytokines and MPA, in the present study we could demonstrate an immunosuppressive effect of MPA on the expression of an important cytokine.  相似文献   
106.
目的:探讨中医活血化瘀结合西医疗法是否具有延缓慢性肾功能不全患者急性肾功能减退的疗效.方法:回顾性分析未行透析的慢性肾功能不全患者32例,近期肾功能急性进行性减退,血尿素氮(blood urea nitrogen,BUN)、肌酐(serum creatinine,SCr)进行性升高.常规治疗基础上,均予以中药保留灌肠30 min,同时加静脉滴注活血化瘀等中西药物治疗14 d.观察治疗前后患者血常规、电解质、肝肾功能以及内生肌酐清除率(creatinine clearance rate,Ccr)的变化.结果:治疗后患者血常规、电解质无明显改变,大多数患者BUN和SCr较治疗前下降,而Ccr升高,总有效率达65.6%.结论:中西医结合疗法可有效逆转慢性肾功能不全患者伴发急性肾功能减退时肾功能的恶化.  相似文献   
107.
Few studies used paired kidneys for comparison between tacrolimus and cyclosporine in renal transplantation. Most of the published data used whole blood trough levels for drug monitoring. However, the use of limited sampling strategy and abbreviated formula to estimate the 12-h area under concentration-time curve (AUC(0-12)) allowed better prediction of drug exposure. Sixty-six first cadaveric renal transplant recipients receiving paired kidneys were randomized to receive either tacrolimus-based (n = 33) or cyclosporine microemulsion (Neoral)-based therapies (n = 33). Abbreviated AUC(0-12) was used for drug monitoring and dose titration. Mean follow-up duration was 2.8 +/- 2 years. The patient and graft survival were comparable. Fewer incidence of acute rejection was observed in tacrolimus group (15% vs. 27.3%) though the difference was not significant (P = 0.23). The absolute value and the rate of decline of creatinine clearance were both significantly better in tacrolimus-treated patients. Prevalence of hypertension, post-transplant diabetes mellitus, infection, and malignancy were similar in both groups. Prevalence of hypercholesterolemia (11/33 vs. 4/33) and gum hypertrophy (6/33 vs. 1/33) was more common in cyclosporine-treated patients (P = 0.04 in both parameters). This was the first prospective, randomized study with paired kidney analysis showing the renal function was significantly better in tacrolimus-treated patients than in cyclosporine-treated patients.  相似文献   
108.
Passenger leukocytes have been suggested to be both pro-tolerant and immunogenic. The opportunity to evaluate the role of allogeneic passenger leukocytes in humans was presented by a 47-year-old man who donated bone marrow to his HLA-identical leukemic sister. Eleven years later he developed renal failure. The sister's marrow was noted to be 100% XY karyotype and free of malignancy. She donated a kidney to her brother. Immunosuppression was tapered following transplantation. After 6 months, the recipient was on monotherapy sirolimus, 1 mg every third day. A surveillance biopsy was normal and sirolimus was stopped. Eight weeks later, he presented with severe rejection that reversed with Thymoglobulin. Renal function returned to baseline and has been stable on conventional immunosuppression.  相似文献   
109.
ABO血型不合的异基因造血干细胞移植--2例报告附文献复习   总被引:2,自引:1,他引:1  
探讨ABO血型不合的异基因造血干细胞移植 (Allo -HSCT)的造血问题。方法 :对 2例患者分别进行异基因外周血造血干细胞移植 (Allo -PBSCT)及脐血造血干细胞移植 (CBSCT) ,用血细胞分离机或 6 %羟乙基淀粉去除移植物中的红细胞 ,定期检测受者血型 ,根据情况输注血细胞。结果 :2例患者全部获得造血重建 ,未出现溶血反应。结论 :ABO血型不合可以进行Allo -HSCT ,去除供者移植物中的红细胞能有效地防止急性溶血反应的发生 ,定期检测受者血型 ,及时调整输血方案有重要的临床意义。  相似文献   
110.
大鼠肾移植模型技术的改进   总被引:6,自引:0,他引:6  
目的 为开展器官移植的实验研究,建立了大鼠异体肾移植模型。方法使用Wistar大鼠分别作为供者和受者,采用原位低温灌洗,肾动脉带一小段主动脉,肾静脉带一小段下腔静脉、输尿管末端带一直径约为0.5cm的膀胱瓣的供者手术方式;受者主动脉与供者主动脉、受者下腔静脉与供者下腔静脉进行端侧吻合,在受者膀胱上剪去一膀胱瓣与供者相同大小的圆瓣,然后进行一层膀胱吻合。结果 第一阶段为实验探索阶段,经过半年近150次的实验摸索,克服了移植物灌洗、血管吻合、膀胱吻合等技术难关,终于建立了比较稳定的大鼠同种异体肾移植模型。第二阶段为模型成熟阶段,冷热缺血时间、血管吻合的速度以及手术时间都比第一阶段有所缩短。手术成功率为85%左右,动物死亡的原因主要为血管吻合口出血、灌洗不良、休克、血栓形成以及膀胱漏尿致弥漫性腹膜炎等。结论 此模型容易掌握,可以在条件比较简单的实验室开展,除常规显微外科器械外不需要特殊的器械或设备。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号